Similar articles for PMID: 28322137

Year	Number of Results
1984	1
1987	1
1991	1
1994	1
1995	2
1997	1
1998	2
2000	3
2001	2
2002	3
2003	4
2004	3
2005	3
2006	3
2007	4
2008	5
2009	3
2010	8
2011	4
2012	8
2013	11
2014	25
2015	37
2016	34
2017	40
2018	50
2019	77
2020	86
2021	71
2022	61
2023	17
2024	1

1

Genetically Engineered Natural Killer Cells as a Means for Adoptive Tumor Immunotherapy.

Michen S, Temme A. Michen S, et al. Crit Rev Immunol. 2016;36(4):329-347. doi: 10.1615/CritRevImmunol.2017019376. Crit Rev Immunol. 2016. PMID: 28322137 Review.

2

Targeting natural killer cells in cancer immunotherapy.

Guillerey C, Huntington ND, Smyth MJ. Guillerey C, et al. Nat Immunol. 2016 Aug 19;17(9):1025-36. doi: 10.1038/ni.3518. Nat Immunol. 2016. PMID: 27540992 Review.

3

Chimeric antigen receptor engineering: a right step in the evolution of adoptive cellular immunotherapy.

Figueroa JA, Reidy A, Mirandola L, Trotter K, Suvorava N, Figueroa A, Konala V, Aulakh A, Littlefield L, Grizzi F, Rahman RL, Jenkins MR, Musgrove B, Radhi S, D'Cunha N, D'Cunha LN, Hermonat PL, Cobos E, Chiriva-Internati M. Figueroa JA, et al. Int Rev Immunol. 2015 Mar;34(2):154-87. doi: 10.3109/08830185.2015.1018419. Int Rev Immunol. 2015. PMID: 25901860 Review.

4

Engineering Natural Killer Cells for Cancer Immunotherapy.

Rezvani K, Rouce R, Liu E, Shpall E. Rezvani K, et al. Mol Ther. 2017 Aug 2;25(8):1769-1781. doi: 10.1016/j.ymthe.2017.06.012. Epub 2017 Jun 28. Mol Ther. 2017. PMID: 28668320 Free PMC article. Review.

5

Improving efficacy of cancer immunotherapy by genetic modification of natural killer cells.

Burga RA, Nguyen T, Zulovich J, Madonna S, Ylisastigui L, Fernandes R, Yvon E. Burga RA, et al. Cytotherapy. 2016 Nov;18(11):1410-1421. doi: 10.1016/j.jcyt.2016.05.018. Epub 2016 Jul 12. Cytotherapy. 2016. PMID: 27421740 Review.

6

Reformation in chimeric antigen receptor based cancer immunotherapy: Redirecting natural killer cell.

Lin C, Zhang J. Lin C, et al. Biochim Biophys Acta Rev Cancer. 2018 Apr;1869(2):200-215. doi: 10.1016/j.bbcan.2018.01.005. Epub 2018 Jan 31. Biochim Biophys Acta Rev Cancer. 2018. PMID: 29378229 Review.

7

Viral and Nonviral Engineering of Natural Killer Cells as Emerging Adoptive Cancer Immunotherapies.

Matosevic S. Matosevic S. J Immunol Res. 2018 Sep 17;2018:4054815. doi: 10.1155/2018/4054815. eCollection 2018. J Immunol Res. 2018. PMID: 30306093 Free PMC article. Review.

8

Next generation natural killer cells for cancer immunotherapy: the promise of genetic engineering.

Daher M, Rezvani K. Daher M, et al. Curr Opin Immunol. 2018 Apr;51:146-153. doi: 10.1016/j.coi.2018.03.013. Epub 2018 Mar 30. Curr Opin Immunol. 2018. PMID: 29605760 Free PMC article. Review.

9

Genetically re-engineered K562 cells significantly expand and functionally activate cord blood natural killer cells: Potential for adoptive cellular immunotherapy.

Ayello J, Hochberg J, Flower A, Chu Y, Baxi LV, Quish W, van de Ven C, Cairo MS. Ayello J, et al. Exp Hematol. 2017 Feb;46:38-47. doi: 10.1016/j.exphem.2016.10.003. Epub 2016 Oct 17. Exp Hematol. 2017. PMID: 27765614 Free article.

10

Engineering NK Cells Modified With an EGFRvIII-specific Chimeric Antigen Receptor to Overexpress CXCR4 Improves Immunotherapy of CXCL12/SDF-1α-secreting Glioblastoma.

Müller N, Michen S, Tietze S, Töpfer K, Schulte A, Lamszus K, Schmitz M, Schackert G, Pastan I, Temme A. Müller N, et al. J Immunother. 2015 Jun;38(5):197-210. doi: 10.1097/CJI.0000000000000082. J Immunother. 2015. PMID: 25962108 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

505 results

Results by year